{{Rsnum
|rsid=2734583
|Gene=BAT1
|Chromosome=6
|position=31537703
|Orientation=minus
|GMAF=0.06612
|Gene_s=BAT1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 18.6 | 79.6
| HCB | 0.7 | 11.7 | 87.6
| JPT | 0.0 | 2.7 | 97.3
| YRI | 0.0 | 19.7 | 80.3
| ASW | 0.0 | 8.8 | 91.2
| CHB | 0.7 | 11.7 | 87.6
| CHD | 0.0 | 7.3 | 92.7
| GIH | 2.0 | 6.9 | 91.1
| LWK | 0.0 | 16.4 | 83.6
| MEX | 0.0 | 5.3 | 94.7
| MKK | 0.6 | 12.2 | 87.2
| TSI | 2.0 | 11.8 | 86.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21912425
|Trait=None
|Title=A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
|RiskAllele=
|Pval=2E-8
|OR=66.8000
|ORtxt=[19.8-225.0]
}}

{{PMID|20017995|OA=1
}} A principal-components-based clustering method to identify multiple variants associated with rheumatoid arthritis and arthritis-related autoantibodies.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}